Akdital S.A (CBSE:AKT)

Market Cap	13.86B -32.4%
Revenue (ttm)	4.85B +27.7%
Net Income	474.60M +19.9%
EPS	n/a
Shares Out	14.16M
PE Ratio	29.21
Forward PE	25.70
Dividend	14.00 (1.43%)
Ex-Dividend Date	Aug 17, 2026

Volume	19,378
Open	1,010.00
Previous Close	1,001.00
Day's Range	970.00 - 1,015.00
52-Week Range	970.00 - 1,484.00
Beta	-0.07
Analysts	Strong Buy
Price Target	1,680.00 (+71.6%)
Est. Earnings	Dec 25, 2026

About Akdital S.A

Akdital S.A operates in the healthcare sector in Morocco. The company offers its services in the areas of surgical, interventional medicine, critical and intensive care, maternity care, oncology, and diagnostic services. It operates private hospitals, multidisciplinary, and clinics and oncology centers. The company was founded in 2011 and is headquartered in Casablanca, Morocco.

• Industry: Hospitals
• Founded: 2011
• Employees: 10,256
• Stock Exchange: Casablanca Stock Exchange
• Ticker Symbol: AKT

Financial Performance

In 2025, Akdital S.A's revenue was 4.41 billion, an increase of 49.40% compared to the previous year's 2.95 billion. Earnings were 443.68 million, an increase of 41.03%.

Analyst Summary

According to 3 analysts, the average rating for AKT stock is "Strong Buy." The 12-month stock price target is MAD 1,680, which is an increase of 71.60% from the latest price.

Price Target

MAD 1,680

(71.60% upside)

Analyst Consensus: Strong Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 30, 2026

Data Sources Report a data error